Pharma & Biotech

The Invesco Dynamic Pharmaceuticals ETF (ticker: PJP) has completed its latest quarterly rebalancing, entering the spring season with a refreshed...

The diagnostics firm T2 Biosystems has formally commenced a voluntary liquidation process, effectively winding down its business operations. This strategic...

Pfizer finds itself at the center of investor attention this Friday, driven by two concurrent events. Beyond the routine distribution...

Investors are bracing for a pivotal week from BioNTech SE, as the biotech firm contends with a significant technical breakdown...

The biopharmaceutical firm BioNxt Solutions is advancing on two critical fronts this month: solidifying its European intellectual property rights and...

Investor sentiment toward Anavex Life Sciences has brightened following the release of new clinical data for its lead Alzheimer's disease...

Within the biotechnology sector, a heightened focus on operational efficiency and clinical trial progress is shaping investor sentiment. For Cardiff...

Investor attention is firmly fixed on the commercial rollout of Omeros Corporation's newly launched therapy following the release of its...

For over a decade, the shares of Rxelite have existed in a state of suspended animation on the public markets....

Biotechnology firm Ocugen has completed patient enrollment for the pivotal Phase 3 clinical trial of its lead candidate, OCU400, a...